Wexford Science + Technology, a BioMed Realty company, announced today the company is investing in its St. Louis team with the hiring of Jerry Crylen as its Senior Director of Development. In this new role Crylen will manage Wexford’s growing real estate portfolio in St. Louis at the nationally acclaimed Cortex Innovation Community and the Bio-Research and Development Growth (BRDG) Park at the Danforth Plant Science Center.
Crylen brings 27 years of experience in domestic and international commercial real estate development to help Wexford grow its presence in St. Louis. Crylen has spent eleven years in St. Louis working in the St. Louis commercial real estate market which will be a tremendous asset as Wexford continues to grow the Cortex and BRDG projects.
“Jerry is a terrific addition to our St. Louis team because of his ability to cultivate relationships combined with his highly-regarded technical skills,” said Dan Cramer, Senior Vice President, Development of Wexford Science + Technology. “This move grows our presence in St. Louis and will allow us to respond even more quickly to the rapidly growing demand in both Cortex and BRDG Park.”
“I’m delighted to be joining the Wexford team and to continue to have a role in St. Louis, which is the regional epicenter of economic recovery and the model Knowledge Community in the Midwest,” said Crylen. “The St. Louis marketplace is the most geographically centric place on the continent, and delivers immediate access to a deep and highly diverse academic, cultural, commercial, financial and highly talented workforce. It’s easy to understand why onshore and offshore growth companies are migrating to the region, and I’m excited to join this incredible development team.”
Prior to joining Wexford, Crylen directed development and investment activities at CA-Ventures, Equity International Properties, and Duke Realty Corporation. He is former Chairman of the Urban Land Institute – St. Louis District Council, and board member of the St. Louis University Urban Planning and Real Estate Development (UPRED) graduate program.
Wexford is the creator of Knowledge Communities in nine cities across the nation, and focuses on innovative adaptive reuse projects in research districts that strengthen the surrounding communities. Wexford’s first project in St. Louis was the BRDG Park at the Danforth Plant Science Center – a three building complex that will ultimately total approximately 450,000 square feet of high-tech wet laboratory office space specifically designed to support the needs of emerging clean-tech, plant and life science businesses. Most recently Wexford developed @4240 in the Cortex Innovation Community, 183,000 square feet of office and lab space that is the focal point of a growing Cortex innovation cluster that will include the Cambridge Innovation Center (CIC-STL), the Venture Café Foundation, Impact Hub, and Tech Shop.
About Wexford Science & Technology
Wexford Science & Technology, LLC, a subsidiary of BioMed Realty, is a real estate investment and development company specializing in facilities for for-profit and not-for-profit institutions, especially universities, university-related research parks and healthcare systems. Wexford brings a unique approach of collaborating with clients to build knowledge communities, which are vibrant, mixed-use, amenity-rich environments that foster innovation. Wexford is building eight other Knowledge Communities across the U.S: the Bio-Research & Development Growth (BRDG) Park at the Danforth Plant Science Center in St. Louis; Hershey Center for Applied Research in Hershey, PA; Innovation Research Park at Old Dominion University in Norfolk, VA; University City Science Center in Philadelphia; University of Maryland BioPark in Baltimore; University of Miami Life Science & Technology Park in Miami; University Technology Park at IIT in Chicago; and Wake Forest Biotech Place at the Wake Forest Innovative Quarter in Winston-Salem, NC.
About BioMed Realty Trust
BioMed Realty, with its trusted expertise and valuable relationships, delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 17.2 million rentable square feet. Additional information is available at www.biomedrealty.com.